These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7535774)

  • 21. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
    Wallasch C; Weiss FU; Niederfellner G; Jallal B; Issing W; Ullrich A
    EMBO J; 1995 Sep; 14(17):4267-75. PubMed ID: 7556068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
    Barth S; Matthey B; Huhn M; Diehl V; Engert A
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):69-78. PubMed ID: 10515679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M
    Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation.
    Kuan CT; Pastan I
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):974-8. PubMed ID: 8577771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins.
    Wels W; Beerli R; Hellmann P; Schmidt M; Marte BM; Kornilova ES; Hekele A; Mendelsohn J; Groner B; Hynes NE
    Int J Cancer; 1995 Jan; 60(1):137-44. PubMed ID: 7814146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells.
    Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I
    J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
    Gawlak SL; Pastan I; Siegall CB
    Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.
    Kunwar S; Pai LH; Pastan I
    J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines.
    Klimka A; Barth S; Drillich S; Wels W; van Snick J; Renauld JC; Tesch H; Bohlen H; Diehl V; Engert A
    Cytokines Mol Ther; 1996 Sep; 2(3):139-46. PubMed ID: 9384698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
    Kondo T; FitzGerald D; Chaudhary VK; Adhya S; Pastan I
    J Biol Chem; 1988 Jul; 263(19):9470-5. PubMed ID: 3132465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.
    Siegall CB; Xu YH; Chaudhary VK; Adhya S; Fitzgerald D; Pastan I
    FASEB J; 1989 Dec; 3(14):2647-52. PubMed ID: 2556314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
    J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
    Barth S; Huhn M; Wels W; Diehl V; Engert A
    Int J Mol Med; 1998 Jan; 1(1):249-56. PubMed ID: 9852227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.
    Wels W; Harwerth IM; Mueller M; Groner B; Hynes NE
    Cancer Res; 1992 Nov; 52(22):6310-7. PubMed ID: 1358432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
    Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity.
    Mixan B; Cohen BD; Bacus SS; Fell HP; Siegall CB
    Oncogene; 1998 Mar; 16(9):1209-15. PubMed ID: 9528863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.